ストックスクリーナーアプリを入手
2.51
0.40%
-0.01
アフターアワーズ：
2.54
0.03
+1.20%
前日終値:
$2.52
開ける：
$2.52
24時間の取引高:
2.21M
Relative Volume:
1.04
時価総額：
$668.01M
収益：
-
当期純損益:
$-208.38M
株価収益率:
-2.0917
EPS:
-1.2
ネットキャッシュフロー:
$-156.57M
1週間 パフォーマンス:
+3.29%
1か月 パフォーマンス:
+8.66%
6か月 パフォーマンス:
+14.09%
1年 パフォーマンス:
-46.25%
1日の値動き範囲:
$2.48
$2.585
1週間の範囲:
$2.41
$2.70
52週間の値動き範囲:
$1.105
$5.00
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
AUTL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
2.51 | 670.67M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-18 | アップグレード | Goldman | Neutral → Buy |
| 2024-11-15 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-03-27 | 再開されました | Wells Fargo | Overweight |
| 2023-03-17 | 開始されました | Bryan Garnier | Buy |
| 2021-06-14 | アップグレード | Jefferies | Hold → Buy |
| 2021-01-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 再開されました | H.C. Wainwright | Buy |
| 2020-07-31 | 開始されました | JP Morgan | Overweight |
| 2020-07-22 | 開始されました | SunTrust | Buy |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2019-09-23 | 開始されました | Needham | Buy |
| 2019-05-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-24 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Autolus Therapeutics Plc Adr (AUTL) 最新ニュース
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks With ‘Strong Buy’ Ratings - Barchart.com
TER’s Stock Market Adventure: -40.87% YTD Growth Amidst Volatility - investchronicle.com
Globe Life Inc (GL) Stock: Navigating a Year of Volatility - investchronicle.com
Autolus Therapeutics’ (AUTL) Buy Rating Reaffirmed at Needham & Company LLC - Defense World
European Commission approves Autolus’ cell therapy for adult leukemia By Investing.com - Investing.com South Africa
European Commission approves Autolus’ cell therapy for adult leukemia - Investing.com India
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) - GlobeNewswire Inc.
Cambridge Investment Research Advisors Inc. Sells 2,160 Shares of Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) - Defense World
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
1,867 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by DAVENPORT & Co LLC - Defense World
DAVENPORT & Co LLC Trims Holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) - Defense World
Vontobel Holding Ltd. Lowers Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World
Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World
Wealth Enhancement Advisory Services LLC Takes $258,000 Position in Taylor Morrison Home Corporation (NYSE:TMHC) - Defense World
TELUS International (Cda) (TSE:TIXT) Trading 2.1% Higher – What’s Next? - Defense World
Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX
NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India
EMA committee endorses Autolus’ leukemia therapy obe-cel By Investing.com - Investing.com South Africa
Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens By Stocktwits - Investing.com India
EMA committee endorses Autolus’ leukemia therapy obe-cel - Investing.com
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocksregister
Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com - Investing.com South Africa
Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com
AUTL’s Market Whiplash: -44.26% YTD Decline, -21.08% Plunge in 30 Days - investchronicle.com
There is no doubt that Autolus Therapeutics plc ADR (AUTL) ticks all the boxes. - Sete News
Autolus Therapeutics plc ADR (AUTL) receives a Buy rating from Goldman - knoxdaily.com
AUTL’s valuation metrics: A comprehensive analysis - uspostnews.com
Market Resilience: Autolus Therapeutics plc ADR (AUTL) Finishes Weak at 1.33, Down -5.00 - DWinneX
Market Update: Goosehead Insurance Inc (GSHD) Sees Positive Movement, Closing at 99.54 - DWinneX
How Do Things Look For Autolus Therapeutics plc ADR (NASDAQ: AUTL) In The Short-Term? - Stocksregister
UK approves Autolus leukemia therapy with conditions By Investing.com - Investing.com India
For Autolus Therapeutics plc ADR [AUTL], Analyst sees a rise to $7.60. What next? - dbtnews.com
UK approves Autolus leukemia therapy with conditions - Investing.com
Autolus Therapeutics plc ADR [NASDAQ: AUTL] Sees Decrease in Stock Value - knoxdaily.com
Market cap of i-80 Gold Corp [IAUX] reaches 279.54M – now what? - dbtnews.com
Daiwa Securities lifts Bilibili Inc ADR [BILI] price estimate. Who else is bullish? - dbtnews.com
Market Watch: Autolus Therapeutics plc ADR (AUTL)’s Noteworthy Gain, Closing at 1.60 - DWinneX
It makes sense and dollars to buy Autolus Therapeutics plc ADR (AUTL) stock - Sete News
How does PROG Holdings Inc (PRG) change from a tortoise to a hare? - Sete News
Investors in cash trouble should check out BBB Foods Inc (TBBB) - Sete News
Take off with Energous Corp (WATT): Get ready for trading - Sete News
The growth track for Protalix BioTherapeutics Inc (PLX) has changed recently - Sete News
Tokio Marine Holdings, Inc. Sponsored ADR (OTCMKTS:TKOMY) Short Interest Update - Defense World
PSQ Holdings Inc (PSQH) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Truist cuts Autolus stock price target to $10, maintains buy rating By Investing.com - Investing.com South Africa
Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India
Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa
Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register
Agilent tech aids in FDA approval of Autolus CAR T therapy - Investing.com UK
Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa
Autolus Therapeutics Plc Adr (AUTL) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.06%
大文字化:
|
ボリューム (24 時間):